Jeff Evanson

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeff Evanson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Common Stock 808,459 $339,553 $0.4200 07 Mar 2024 Direct
Outlook Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Stock Option (Right to Buy) 25,000 20 Mar 2024 Direct

Insider Reports Filed by Jeff Evanson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 20 Mar 2024 1 $0 4 CHIEF COMMERCIAL OFFICER 22 Mar 2024, 17:00
OTLK Outlook Therapeutics, Inc. 07 Mar 2024 1 +$26,243 4 CHIEF COMMERCIAL OFFICER 11 Mar 2024, 16:43
OTLK Outlook Therapeutics, Inc. 17 Apr 2023 1 $0 4 Chief Commercial Officer 19 Apr 2023, 17:41
OTLK Outlook Therapeutics, Inc. 20 Jan 2023 1 -$296,370 4 Chief Commercial Officer 24 Jan 2023, 19:08
OTLK Outlook Therapeutics, Inc. 17 Jan 2023 3 -$203,726 4 Chief Commercial Officer 19 Jan 2023, 19:05
OTLK Outlook Therapeutics, Inc. 31 Mar 2022 1 $0 4 Chief Commercial Officer 04 Apr 2022, 18:47
OTLK Outlook Therapeutics, Inc. 21 Dec 2021 1 $0 4 Chief Commercial Officer 23 Dec 2021, 16:32
OTLK Outlook Therapeutics, Inc. 03 Dec 2021 1 +$47,168 4 Chief Commercial Officer 06 Dec 2021, 16:25